NSE filing, NSE: LALPATHLAB. Summary written from the filing by ALFA Finder's alert engine.
Dr. Lal Pathlabs Ltd: key numbers
- Share price
- ₹1,906.40
- Market cap
- ₹31,999 Cr
- Revenue (annual)
- ₹2,763 Cr
- Net profit (annual)
- ₹504.8 Cr
- P/E (TTM)
- 59.0×Sector 52.8×
- Promoter holding
- 52.93%-0.26% QoQ
- FII holding
- 18.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Lal Pathlabs Ltd
All →Dr. Lal Pathlabs Board Meeting Date
Dr. Lal PathLabs updated its 4 November 2026 board meeting notice to add a possible second interim dividend. The meeting will also approve unaudited quarterly results.
Dr. Lal Pathlabs Acquisition Worth ₹30.3 Cr
Dr. Lal PathLabs subscribed to WOS PUPL equity to fund PUPL's buyout of remaining 30% in CentraPath Labs for ₹30.3 Crore. CentraPath becomes a wholly owned subsidiary.
- Value
- ₹30.30 Cr
Dr. Lal Pathlabs Other Announcement
Dr. Lal PathLabs submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, received from its RTA.
Dr. Lal Pathlabs Legal & Regulatory
Dr. Lal PathLabs disclosed an ITAT tax appeal against a favorable order for Rs.32.66 Crore ESOP expense relief (AY 2022-23). The company expects no material financial impact.
- Value
- ₹32.66 Cr
Dr. Lal Pathlabs Other Announcement
Dr. Lal PathLabs reported PIT disclosures for trades by designated persons and its Employee Welfare Trust, totaling approximately ₹0.83 Crore. These involved ESOP allotments and market sales.
- Value
- ₹0.09 Cr
Dr. Lal Pathlabs Acquisition Worth ₹38 Cr
Dr. Lal Path Labs' subsidiary completed the acquisition of an 80% stake in Sunshine Healthcare Limited, Ghana, for Rs.38.00 Crore. The target is now a subsidiary.
- Value
- ₹38.00 Cr
Other management change announcements
All →Kingfa Science & Technology (India) Management Change
Kingfa disclosed that Nilima Ramrao Shinde ceased as Non-Executive Independent Director on tenure completion, effective 31 October 2026. No monetary value is involved.
Ashika Global Securities Management Change
Ashika Global Securities disclosed the re-appointment of Amit Jain as Whole-Time Director of unlisted material subsidiary Ashika Stock Services for three years from 1 November 2026. The filing reports a senior management reappointment with no monetary value.
- Execution
- 3 years, 01 November 2026 to 31 October 2029
Mahesh Developers Management Change
Mahesh Developers appointed Sunny Chowdhry as Executive Director and Ashutosh Kumar Beri as Non-Executive Director, effective 30 October 2026. Both have 60-month terms, strengthening board leadership.
- Execution
- 60 months
Jaiprakash Power Ventures Management Change
Mukesh M. Shah assumed office as Independent Director of Jaiprakash Power Ventures effective 1 November 2026. No monetary value is involved in this director appointment.
Indian Oil Corporation Management Change
Indian Oil disclosed that two senior management personnel, Shri Subrat Kar and Dr. Alex C Pulikottil, superannuated effective 31 October 2026. The filing reports a senior management departure with no monetary value.
Jindal Steel Management Change
Jindal Steel's Head of Human Resources, Sukhjit S. Pasricha, ceased to be in the company's services on 31 October 2026. The senior management resignation has no associated monetary value.